Study: Sleeping aids could increase the risk of Alzheimer's

A new study from the University of Washington School of Pharmacy found that over-the-counter sleeping drugs could increase the risk of Alzheimer's disease.

The study, published in the journal JAMA Internal Medicine on Monday, found that some sleep aids and anti-allergy pills contain "anticholinergic" blocking effects, which, if taken in large doses, can increase the risk of dementia and Alzheimer's. Anticholinergic drugs block acetylcholine, a chemical transmitter in the nervous system that Alzheimer's patients often lack.

The researchers suggested that doctors prescribe lower doses and fewer anticholinergic drugs for older patients, though more research is needed to understand sleep aids' potential risks.

The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Sign up